Dark Forest Capital Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
ACA
BI
SL
Dark Forest Capital Management's KYMR Position: Q2 2026 in Review
Dark Forest Capital Management sold out of Kymera Therapeutics (KYMR) in Q2 2026, closing a stake of 21,760 shares — an estimated $1.81M sold.
Dark Forest Capital Management first reported a position in KYMR in Q2 2021 and held it in 16 quarters. The position peaked at $3.05M in Q4 2025. 277 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.
- Dark Forest Capital Management reported no remaining Kymera Therapeutics position as of Q2 2026 after selling out during the quarter.
- Dark Forest Capital Management sold 21,760 Kymera Therapeutics shares in Q2 2026, an estimated $1.81M.
- Dark Forest Capital Management first reported a position in Kymera Therapeutics in Q2 2021 and held it in 16 quarters.
- Dark Forest Capital Management's Kymera Therapeutics position peaked at $3.05M in Q4 2025.
- 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.
Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.